FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
schedule
18:56
visibility
38 visualizações
Fonte: Wired
Ler artigo original →
auto_awesome Este artigo foi traduzido automaticamente e pode conter imprecisões.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.